Cargando…
The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study
INTRODUCTION: The frozen elephant trunk technique (FET) has become routine for aortic arch and descending aortic repair. New hybrid prosthesis models are constantly being developed to increase effectiveness and durability of aortic repair. Recently, concerns were raised regarding increased post-oper...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988725/ https://www.ncbi.nlm.nih.gov/pubmed/36633731 http://dx.doi.org/10.1007/s12325-022-02418-5 |
_version_ | 1784901628679159808 |
---|---|
author | El-Sayed Ahmad, Ali Silaschi, Miriam Borger, Michael Seidiramool, Vahid Hamiko, Marwan Leontyev, Sergey Zierer, Andreas Doss, Mirko Etz, Christian D. Benedikt, Peter Bramlage, Peter Bakhtiary, Farhad |
author_facet | El-Sayed Ahmad, Ali Silaschi, Miriam Borger, Michael Seidiramool, Vahid Hamiko, Marwan Leontyev, Sergey Zierer, Andreas Doss, Mirko Etz, Christian D. Benedikt, Peter Bramlage, Peter Bakhtiary, Farhad |
author_sort | El-Sayed Ahmad, Ali |
collection | PubMed |
description | INTRODUCTION: The frozen elephant trunk technique (FET) has become routine for aortic arch and descending aortic repair. New hybrid prosthesis models are constantly being developed to increase effectiveness and durability of aortic repair. Recently, concerns were raised regarding increased post-operative bleeding using a new-generation hybrid prosthesis (E-vita(®) OPEN NEO, CryoLife Inc. JOTEC GmbH, Hechingen, Germany). We report the outcomes of a multi-centre experience of using the E-vita OPEN NEO. METHODS: All patients undergoing aortic surgery at five European centres using the E-vita OPEN NEO from 2020 to 2022 were included (n = 22). The primary endpoint was the amount of chest drain fluid after 24 h and re-thoracotomy rate for bleeding. RESULTS: Median patient age was 62.5 ± 12.6 years, 50.0% (11/22 patients) were female and 27.3% (6/22) of procedures were re-operative cardiac surgeries. Aortic dissection was present in 54.5% (12/22). The median cardiopulmonary bypass time was 148 min and ischaemia time was 84 min. Mortality at 30 days was 4.5% (1/22) and the stroke rate was 18.2% (4/22). The rate of re-thoracotomy for bleeding was 4.5% (1/22) with a median amount of chest drain fluid within 24 h of 569 (IQR 338–910) ml. There were no device-associated adverse events. CONCLUSIONS: Use of this new-generation hybrid prosthesis for FET was safe and effective. Patient follow-up was largely uneventful given the extent of the procedures performed. In particular, bleeding events were uncommon in this cohort of patients comprising many aortic dissections and re-operative procedures. No increase in oozing was observed. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9988725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-99887252023-03-08 The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study El-Sayed Ahmad, Ali Silaschi, Miriam Borger, Michael Seidiramool, Vahid Hamiko, Marwan Leontyev, Sergey Zierer, Andreas Doss, Mirko Etz, Christian D. Benedikt, Peter Bramlage, Peter Bakhtiary, Farhad Adv Ther Original Research INTRODUCTION: The frozen elephant trunk technique (FET) has become routine for aortic arch and descending aortic repair. New hybrid prosthesis models are constantly being developed to increase effectiveness and durability of aortic repair. Recently, concerns were raised regarding increased post-operative bleeding using a new-generation hybrid prosthesis (E-vita(®) OPEN NEO, CryoLife Inc. JOTEC GmbH, Hechingen, Germany). We report the outcomes of a multi-centre experience of using the E-vita OPEN NEO. METHODS: All patients undergoing aortic surgery at five European centres using the E-vita OPEN NEO from 2020 to 2022 were included (n = 22). The primary endpoint was the amount of chest drain fluid after 24 h and re-thoracotomy rate for bleeding. RESULTS: Median patient age was 62.5 ± 12.6 years, 50.0% (11/22 patients) were female and 27.3% (6/22) of procedures were re-operative cardiac surgeries. Aortic dissection was present in 54.5% (12/22). The median cardiopulmonary bypass time was 148 min and ischaemia time was 84 min. Mortality at 30 days was 4.5% (1/22) and the stroke rate was 18.2% (4/22). The rate of re-thoracotomy for bleeding was 4.5% (1/22) with a median amount of chest drain fluid within 24 h of 569 (IQR 338–910) ml. There were no device-associated adverse events. CONCLUSIONS: Use of this new-generation hybrid prosthesis for FET was safe and effective. Patient follow-up was largely uneventful given the extent of the procedures performed. In particular, bleeding events were uncommon in this cohort of patients comprising many aortic dissections and re-operative procedures. No increase in oozing was observed. GRAPHICAL ABSTRACT: [Image: see text] Springer Healthcare 2023-01-12 2023 /pmc/articles/PMC9988725/ /pubmed/36633731 http://dx.doi.org/10.1007/s12325-022-02418-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research El-Sayed Ahmad, Ali Silaschi, Miriam Borger, Michael Seidiramool, Vahid Hamiko, Marwan Leontyev, Sergey Zierer, Andreas Doss, Mirko Etz, Christian D. Benedikt, Peter Bramlage, Peter Bakhtiary, Farhad The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study |
title | The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study |
title_full | The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study |
title_fullStr | The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study |
title_full_unstemmed | The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study |
title_short | The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study |
title_sort | frozen elephant technique using a novel hybrid prosthesis for extensive aortic arch disease: a multicentre study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988725/ https://www.ncbi.nlm.nih.gov/pubmed/36633731 http://dx.doi.org/10.1007/s12325-022-02418-5 |
work_keys_str_mv | AT elsayedahmadali thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT silaschimiriam thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT borgermichael thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT seidiramoolvahid thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT hamikomarwan thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT leontyevsergey thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT ziererandreas thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT dossmirko thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT etzchristiand thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT benediktpeter thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT bramlagepeter thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT bakhtiaryfarhad thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT elsayedahmadali frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT silaschimiriam frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT borgermichael frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT seidiramoolvahid frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT hamikomarwan frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT leontyevsergey frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT ziererandreas frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT dossmirko frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT etzchristiand frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT benediktpeter frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT bramlagepeter frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy AT bakhtiaryfarhad frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy |